Public health officials are investigating a multistate outbreak of Salmonella infections exhibiting resistance to multiple antibiotics, linked to certain lots of moringa powder capsules. The Centers for Disease Control and Prevention (CDC) announced the outbreak on February 13, 2026, reporting seven confirmed cases across seven states. Whereas three individuals have been hospitalized, no deaths have been reported as of today.
The outbreak strain of Salmonella is particularly concerning due to its extensive drug resistance, meaning common antibiotics used to treat these infections may be ineffective. This poses a challenge for clinicians and underscores the importance of accurate diagnosis and appropriate treatment strategies. The CDC is working to further characterize the resistance patterns of this strain and provide guidance to healthcare professionals.
The implicated product is moringa powder capsules sold under the Rosabella brand and distributed by Ambrosia Brands LLC. These capsules are packaged in white plastic bottles with a green label and are primarily sold online through the company’s website, as well as major online retailers including Amazon, eBay, TikTok Shop, and Shein. The company has initiated a recall of 52 lot codes, all with expiration dates in 2027. Consumers can find a complete list of affected lot codes on the Food and Drug Administration (FDA) website.
Recall Details and Consumer Guidance
The CDC advises consumers to immediately stop using any Rosabella moringa powder capsules with the recalled lot codes. These capsules should be discarded or returned to the place of purchase. Individuals should likewise thoroughly wash any items or surfaces that may have come into contact with the product to prevent potential contamination.
Symptoms of Salmonella infection typically include diarrhea, fever, and abdominal cramps, often beginning 6 hours to 6 days after infection. The CDC urges anyone experiencing severe symptoms, such as high fever, dehydration, or bloody diarrhea, to seek medical attention promptly. While most people recover from Salmonella infections without antibiotic treatment, the drug-resistant nature of this particular strain necessitates careful medical evaluation.
Antibiotic Resistance and Treatment Considerations
The CDC notes that the Salmonella strain associated with this outbreak demonstrates resistance not only to first-line antibiotics typically used for Salmonella infections but also to alternative treatments. Resistance to beta-lactam antibiotics, including meropenem and other carbapenems, has also been observed.
The agency recommends that, when possible, antibiotic treatment be guided by antimicrobial susceptibility testing to determine the most effective course of action. In complicated or extensively drug-resistant cases, consultation with an infectious disease specialist may be necessary. This outbreak highlights the growing concern of antimicrobial resistance and the need for continued surveillance and responsible antibiotic use.
This outbreak is separate from another Salmonella investigation announced by the CDC in January, which was linked to dietary supplements containing moringa leaf powder. According to the CDC, the two outbreaks are unrelated.
As investigations continue, public health officials will continue to monitor the situation and provide updates as new information becomes available. Consumers are encouraged to stay informed and follow the CDC’s recommendations to protect their health.
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Share this information with your network to help raise awareness about this outbreak and protect others. Have you or someone you realize been affected by this outbreak? Share your experience in the comments below.
